1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  6. QuickLinks
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  6. QuickLinks
  1. Launch

Copptech UK Limited

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Location

Milton Keynes UK

Primary Industry

Biotechnology

About

Based in UK, Copptech UK Limited operates as a biotechnology research platform that eliminates viruses and bacteria. In October 2022, Copptech UK Limited raised GBP 5 million in venture funding from new investor Foresight Group. Copptech UK Limited particles eliminate and inhibit the reproduction of pathogenic microorganisms in-contact with any surfaces, thus creating a protective shield between the source of infection and people, enabling clients to incorporate antibacterial protection throughout the day.
Current Investors
Foresight Group Holdings

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Biotechnology, Chemicals
Website
www.copptech.com
Company Stage
Growth Stage/Expansion
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.